APA (7th ed.) Citation

K, I., D, A., T, T., T, S., Y, M., T, F., . . . N, F. (2026). Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3. International journal of hematology, 123(5), 696. https://doi.org/10.1007/s12185-025-04139-1

Chicago Style (17th ed.) Citation

K, Izutsu, et al. "Three-year Follow-up of Epcoritamab Therapy in Japanese Patients with Relapsed/refractory Follicular Lymphoma in EPCORE NHL-3." International Journal of Hematology 123, no. 5 (2026): 696. https://doi.org/10.1007/s12185-025-04139-1.

MLA (9th ed.) Citation

K, Izutsu, et al. "Three-year Follow-up of Epcoritamab Therapy in Japanese Patients with Relapsed/refractory Follicular Lymphoma in EPCORE NHL-3." International Journal of Hematology, vol. 123, no. 5, 2026, p. 696, https://doi.org/10.1007/s12185-025-04139-1.